Navigation Links
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40.
Date:7/24/2014

sease and as key components in pharmaceutical, diagnostics and high technology manufacturing.  Sigma-Aldrich customers include more than one million scientists and technologists in life science companies, university and government institutions, hospitals and a wide range of industrial companies.  The Company operates in 37 countries and has more than 9,000 employees whose objective is to provide excellent service worldwide.  Sigma-Aldrich is committed to accelerating customer success through innovation and leadership in Life Science, Technology and Service.  For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.

Non-GAAP Financial Measures:  The Company supplements its disclosures made in accordance with accounting principles generally accepted in the United States (U.S. GAAP) with certain non-GAAP financial measures.  The Company does not, and does not suggest investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, GAAP financial information.  These non-GAAP measures may not be consistent with the presentation by other companies inside or outside of the Company's industry.  Whenever the Company uses such non-GAAP measures, it provides a reconciliation of such measures to the most closely applicable GAAP measure.  See the Supplemental Financial Information on pages 11 and 12 of this release for these reconciliations.

With approximately 60% of sales denominated in currencies other than the U.S. dollar, management uses currency adjusted sales growth when analyzing Company performance, and believes it is useful as well to investors to judge the Company's performance.  Organic sales growth data presented in this release excludes currency and acquisition/divestiture impacts.  The Company calculates the impact of changes in foreign currency exchange rates by multiplying current
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
2. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
3. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
4. Sigma-Aldrich Enhances Customer Focus in China - Unveils Dynamic New Website and Expands Product Offering Through Vetec Brand
5. Sigma-Aldrich (NASDAQ: SIAL) Declares $0.20 Quarterly Dividend
6. Sigma-Aldrich Aligns Into Three New Market-Focused Business Units
7. Sigma-Aldrich Reports Record Full Year 2012 Results. Reports Q4 2012 Diluted EPS Of $0.96. Q4 2012 Sales Increased 7%. Full Year 2012 Adjusted Diluted EPS Was $3.85. Expects Full Year 2013 Adjusted Diluted EPS To Increase To $4.10 - $4.20.
8. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
9. Sigma-Aldrich Announces Q1 2013 Earnings Conference Call
10. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2013 Sales And EPS Of $675 Million And $1.01, Respectively, Both Record Quarterly Highs. Reaffirms Full Year 2013 Diluted Adjusted EPS Outlook Of $4.10 To $4.20.
11. Sigma-Aldrich Corporation Declares $0.215 Per Share Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Cardinal Innovations Healthcare Solutions , ... high-touch service delivery, is featuring its highly successful ... National Council for Behavioral Health,s annual National Conference ... 2015, at the Gaylord Palms Resort and Convention ... attracts participants from mental health and addiction treatment ...
(Date:4/20/2015)... 20, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... and drug-delivery therapies, today shared highlights of new ... Cancer Research (AACR) annual meeting. Halozyme also announced ... Phase 2 study in pancreatic cancer, Study 202, ... American Society of Clinical Oncology (ASCO). ...
(Date:4/20/2015)... , April 20, 2015  Published results ... trends in the ability of Neuraltus Pharmaceuticals ... of amyotrophic lateral sclerosis (ALS, also known as ... treatment period. While NP001,s slowing of decline in ... was not statistically significant, clinically meaningful slowing of ...
Breaking Medicine Technology:Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 2Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5
... Pursuant to the filing of a Form 13D with the ... global leader in protection solutions, today announced it has made ... acquired 9.66% of the issued and outstanding shares of common ... manufactures and sells a comprehensive line of safety garments and ...
... SCOLR Pharma, Inc. (OTCQB: SCLR) today announced that ... its extended-release nutritional products based on the Company,s proprietary ... first significant direct retail sales of its nutritional products. ... CEO, said, "Shipment of these initial orders marks an ...
Cached Medicine Technology:SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products 2
(Date:4/20/2015)... Mutare Health, a Strategic Business ... Lawrence Kosinski, MD, MBA, AGAF, to serve as ... a unique combination of medical experience, technical expertise, ... Health team as it continues to develop ... of care in the healthcare environment. He is ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Goodreads is ... Health Insurance: Why It’s Good for You and Your ... Paul Zane Pilzer and Rick Lindquist have released ... Insurance: Why It’s Good for You and Your Company. ... employer health insurance woes - employer-funded individual health insurance. ...
(Date:4/20/2015)... April 20, 2015 Advance Home Care ... personal matter that many customers would prefer not to share ... March 30th a discreet delivery method allowing customers to order ... at their home without fear of a neighbor or passerby ... method is available now on all orders and no minimum ...
(Date:4/20/2015)... Florida Hospital at Connerton Long Term ... from Select Medical, during the annual ceremony hosted at ... Chief Operating Officer, Debi Martoccio, received the Leadership Award ... of six recipients out of 113 hospitals nationwide. The ... for the contributions to the community as well as ...
(Date:4/20/2015)... 1% for the Planet , one of the ... Williams, the network’s Director of Partnerships, will step into the ... been part of 1% for the Planet since early 2014, ... Northern Forest Canoe Trail, a 1% for the Planet nonprofit ... of and advocacy for the outdoors, a commitment which is ...
Breaking Medicine News(10 mins):Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 3Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3
... , WEDNESDAY, Jan. 5 (HealthDay News) -- Women with ... to have a gene thought to be connected to the ... help researchers gain more insight into the development of MS, ... particularly among women. Although no one knows what causes MS, ...
... Lou Gehrig,s disease, or amyotrophic lateral sclerosis (ALS), ... clumps in brain and spinal-cord cells that include an ... building block of the lesions formed by these clumps. ... Journal of Clinical Investigation , a team led by ...
... are reporting development of a less expensive, more eco-friendly method ... may be a more healthful form of water. Their report ... Research . Changgong Meng and Feng Huang note ... mixture of H2O and tiny amounts of D2O about ...
... of researchers at the Columbia University College of Dental ... key role in vascular pathogenesis, specifically atherosclerosis, or what ... the number one cause of death in the ... in cardiovascular diseases has been challenging because researchers have ...
... maximum temperature of children,s bath water can significantly reduce ... the risk of scalding, according to researchers at The ... partnership with Glasgow Housing Association, found that families with ... and cold water pipes in their bathroom had bath ...
... New Rochelle, NY, January 5, 2011A new, simplified method ... of shuttling genes into host cells will help advance ... into large animal studies and human clinical trials. The ... an article published Instant Online ahead of publication in ...
Cached Medicine News:Health News:Study Sheds Light on Genetic Risk of MS 2Health News:Malfunctioning gene associated with Lou Gehrig's disease leads to nerve-cell death in mice 2Health News:Bacteria eyed for possible role in atherosclerosis 2Health News:Bacteria eyed for possible role in atherosclerosis 3Health News:Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds 2Health News:Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds 3Health News:Faster, scalable method for producing AAV-based gene transfer vectors 2
Bio-Rad's Liquichek™ D-dimer Control provides the laboratory with a liquid, trilevel, human plasma based control for the monitoring of D-dimer testing on most automated coagulation, chemistry a...
Lyphochek Coagulation Control is a human plasma control for monitoring the performance of routine coagulation tests. It has an extended reconstituted stability which helps reduce waste and save money...
Lyphochek Diabetes Control is a human whole blood based product used to monitor hemoglobin fractions associated with diabetes, including Hemoglobins A1, A1C, F and Total Glycated Hemoglobin....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Medicine Products: